SCHEMBL21701159

SCHEMBL21701159

COC(=O)C1CCC(=C(C#N)C#N)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
PPM1B O75688 1/20 0.36
PTPN1 P18031 1/20 0.36
PPP1CC P36873 1/20 0.36
POLB P06746 2/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
BRD4 O60885 1/20 0.35
ALDH1A1 P00352 2/20 0.35
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA4 P43681 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20990681 0.81 DRD2 (0.46) DRD2DRD3SMN1; SMN2PPM1BPTPN1
Water SCHEMBL28039499 0.74 TP53 (0.41) TP53SMN1; SMN2PPM1BPTPN1PPP1CC
SCHEMBL791232 0.72 BRD4 (0.46) TP53SMN1; SMN2PPM1BPTPN1POLB
SCHEMBL20990709 0.71 MTNR1A (0.46) DRD2DRD3SMN1; SMN2LMNAALDH1A1
SCHEMBL3879955 0.71 TP53 (0.44) TP53SMN1; SMN2PPM1BPTPN1PPP1CC
Acetonitrile SCHEMBL28144367 0.71 SMN1; SMN2 (0.55) TP53SMN1; SMN2PPM1BPTPN1PPP1CC
SCHEMBL244740 0.71
SCHEMBL2948892 0.71 TP53 (0.56) TP53SMN1; SMN2PPM1BPTPN1PPP1CC
SCHEMBL2200767 0.71 TP53 (0.56) TP53SMN1; SMN2PPM1BPTPN1PPP1CC
SCHEMBL74396 0.71 TP53 (0.56) TP53SMN1; SMN2PPM1BPTPN1PPP1CC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912704-B2 Methods and compositions for substituted arylcycloheptane analogs UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2024-02-27 US disclosed
US-20210300928-A1 METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2021-09-30 US disclosed
WO-2020033567-A1 METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) 2020-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300928-A1 METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS AHR, HCCS, HMBS DRD2 1498/4885DRD3 1435/4885TP53 2456/4885
US-11912704-B2 Methods and compositions for substituted arylcycloheptane analogs AHR, HCCS, HMBS DRD2 1498/4885DRD3 1435/4885TP53 2456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.